Cost Effectiveness of Apixaban and Enoxaparin for the Prevention of Venous Thromboembolism After Total Knee Replacement in China
Crossref DOI link: https://doi.org/10.1007/s40261-016-0444-5
Published Online: 2016-08-31
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yan, Xiaoyu
Gu, Xiaohua
Zhou, Lei
Lin, Houweng
Wu, Bin
Funding for this research was provided by:
Sanofi-Aventis Hellas
License valid from 2016-08-31